North America Autoimmune Disease Diagnostics Market Growth was valued at USD 5.5 billion in 2019 and is expected to witness 2.3% CAGR from 2020 to 2026. Rising awareness among patients pertaining to the autoimmune diseases is one of the major drivers for the regional market growth.

North America Autoimmune Disease Diagnostics Market Share 2026, Report Analysis

North America Autoimmune Disease Diagnostics Market Value By Product (Systemic Autoimmune Disease {Rheumatoid arthritis, Ankylosing spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), Localized Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2020 – 2026 

Report Content

Chapter 1.&nbsp;&nbsp;&nbsp;&nbsp; Methodology

1.1.&nbsp;&nbsp; Definition and forecast parameters

1.1.1.&nbsp; Definitions

1.1.2.&nbsp; Methodology and forecast parameters&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

1.2.&nbsp;&nbsp; Data sources&nbsp;

1.3.&nbsp;&nbsp; References &amp; sources

1.3.1.&nbsp; Secondary

1.3.2.&nbsp; Primary

Chapter 2.&nbsp;&nbsp;&nbsp;&nbsp; Executive Summary

2.1.&nbsp;&nbsp; North America autoimmune disease diagnostics industry summay, 2015 - 2026

2.1.1.&nbsp; Country trends

2.1.2.&nbsp; Product trends

Chapter 3.&nbsp;&nbsp;&nbsp;&nbsp; Industry Insights

3.1.&nbsp;&nbsp; Industry segmentation

3.2.&nbsp;&nbsp; Industry outlook, 2015 - 2026

3.3.&nbsp;&nbsp; Major factor analysis

3.3.1.&nbsp; Drivers

3.3.1.1.&nbsp;&nbsp; Increasing funding for research in U.S.

3.3.1.2.&nbsp;&nbsp; High prevalence of autoimmune diseases

3.3.1.3.&nbsp;&nbsp; Favorable government initiatives in U.S.

3.3.1.4.&nbsp;&nbsp; Rising patient awareness

3.3.1.5.&nbsp;&nbsp; Technological advancements.

3.3.2.&nbsp; Restraints &amp; challenges

3.3.2.1.&nbsp;&nbsp; Lack of skilled healthcare practitioners

3.4.&nbsp;&nbsp; Porter&rsquo;s analysis

3.5.&nbsp;&nbsp; Competitive review, 2019

3.6.&nbsp;&nbsp; PEST analysis

Chapter 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; North America Autoimmune Disease Diagnostics Market, By Product

4.1.&nbsp;&nbsp; Key trends in North America autoimmune disease diagnostics, by product

4.2.&nbsp;&nbsp; Systemic autoimmune disease

4.2.1.&nbsp; Market estimates and forecast, by country, 2015 - 2026&nbsp; (USD Million)

4.2.2.&nbsp; Rheumatoid arthritis

4.2.2.1.&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026&nbsp; (USD Million)

4.2.3.&nbsp; Ankylosing spondylitis

4.2.3.1.&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026&nbsp; (USD Million)

4.2.4.&nbsp; Systemic lupus erythematosus

4.2.4.1.&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026&nbsp; (USD Million)

4.2.5.&nbsp; Others

4.2.5.1.&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026&nbsp; (USD Million)

4.3.&nbsp;&nbsp; Localized autoimmune disease

4.3.1.&nbsp; Market estimates and forecast, by country, 2015 - 2026&nbsp; (USD Million)

Chapter 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; North America Autoimmune Disease Diagnostics Market, By Country

5.1.&nbsp;&nbsp; Key trends in North America autoimmune disease diagnostics, by country

5.2.&nbsp;&nbsp; U.S.

5.2.1.&nbsp; Market estimates and forecast, by product, 2015 - 2026&nbsp; (USD Million)

5.2.1.1.&nbsp;&nbsp; Market estimates and forecast, by systemic autoimmune disease, 2015 - 2026&nbsp; (USD Million)

5.3.&nbsp;&nbsp; Canada

5.3.1.&nbsp; Market estimates and forecast, by product, 2015 - 2026&nbsp; (USD Million)

5.3.1.1.&nbsp;&nbsp; Market estimates and forecast, by systemic autoimmune disease, 2015 - 2026&nbsp; (USD Million)

Chapter 6.&nbsp;&nbsp;&nbsp;&nbsp; Company Profiles

6.1.&nbsp;&nbsp; Abbott Laboratories

6.1.1.&nbsp; Business overview

6.1.2.&nbsp; Financial data

6.1.3.&nbsp; Product landscape

6.1.4.&nbsp; Strategic outlook

6.2.&nbsp;&nbsp; Beckman Coulter, Inc.,

6.2.1.&nbsp; Business overview

6.2.2.&nbsp; Financial data

6.2.3.&nbsp; Product landscape

6.2.4.&nbsp; Strategic outlook

6.3.&nbsp;&nbsp; Bio-Rad Laboratories

6.3.1.&nbsp; Business overview

6.3.2.&nbsp; Financial data

6.3.3.&nbsp; Product landscape

6.3.4.&nbsp; Strategic outlook

6.4.&nbsp;&nbsp; Hemagen Diagnostics

6.4.1.&nbsp; Business overview

6.4.2.&nbsp; Financial data

6.4.3.&nbsp; Product landscape

6.4.4.&nbsp; Strategic outlook

6.5.&nbsp;&nbsp; Inova Diagnostics, Inc.,

6.5.1.&nbsp; Business overview

6.5.2.&nbsp; Financial data

6.5.3.&nbsp; Product landscape

6.5.4.&nbsp; Strategic outlook

6.6.&nbsp;&nbsp; Quest Diagnostics,

6.6.1.&nbsp; Business overview

6.6.2.&nbsp; Financial data

6.6.3.&nbsp; Product landscape

6.6.4.&nbsp; Strategic outlook

6.7.&nbsp;&nbsp; SQI diagnostics

6.7.1.&nbsp; Business overview

6.7.2.&nbsp; Financial data

6.7.3.&nbsp; Product landscape

6.7.4.&nbsp; Strategic outlook

6.8.&nbsp;&nbsp; F. Hoffmann-La Roche Ltd&nbsp;&nbsp;

6.8.1.&nbsp; Business overview

6.8.2.&nbsp; Financial data

6.8.3.&nbsp; Product landscape

6.8.4.&nbsp; Strategic outlook

6.9.&nbsp;&nbsp; Siemens Healthineers

6.9.1.&nbsp;&nbsp; Business overview

6.9.2.&nbsp;&nbsp; Financial data

6.9.3.&nbsp;&nbsp; Product landscape

6.9.4.&nbsp;&nbsp; Strategic outlook

6.10. Crescendo Bioscience, Inc.

6.10.1. Business overview

6.10.2. Financial data

6.10.3. Product landscape

6.10.4. Strategic outlook

Data Tables

TABLE 1.&nbsp;&nbsp; North America market estimates by country, (USD Mn), 2015 - 2019

TABLE 2.&nbsp;&nbsp; North America market forecast by country, (USD Mn), 2020 - 2026

TABLE 3.&nbsp;&nbsp; North America market estimates by product, (USD Mn), 2015 - 2019

TABLE 4.&nbsp;&nbsp; North America market forecast by product, (USD Mn), 2020 &ndash; 2026

TABLE 5.&nbsp;&nbsp; Competition review

TABLE 6.&nbsp;&nbsp; North America product market estimates, (USD Mn), 2015 &ndash; 2019

TABLE 7.&nbsp;&nbsp; North America product market estimates, (USD Mn), 2020 &ndash; 2026

TABLE 8.&nbsp;&nbsp; North America systemic autoimmune disease diagnostics market estimates, (USD Mn), 2015 &ndash; 2019

TABLE 9.&nbsp;&nbsp; North America systemic autoimmune disease diagnostics market forecast, (USD Mn), 2020 &ndash; 2026

TABLE 10. U.S. product market estimates, (USD Mn), 2015 &ndash; 2019

TABLE 11. U.S.product market estimates, (USD Mn), 2020 &ndash; 2026

TABLE 12. U.S. systemic autoimmune disease diagnostics market estimates, (USD Mn), 2015 - 2019

TABLE 13. U.S. systemic autoimmune disease diagnostics market forecast, (USD Mn), 2020 - 2026

TABLE 14. Canada product market estimates, (USD Mn), 2015 &ndash; 2019

TABLE 15. Canada product market estimates, (USD Mn), 2020 - 2026

TABLE 16. Canada systemic autoimmune disease diagnostics market estimates, (USD Mn), 2015 - 2019

TABLE 17. Canada systemic autoimmune disease diagnostics market forecast, (USD Mn), 2020 - 2026

&nbsp;

Charts &amp; Figures

FIG 1.&nbsp;&nbsp;&nbsp;&nbsp; Industry segmentation

FIG 2.&nbsp;&nbsp;&nbsp;&nbsp; North America autoimmune disease diagnostics industry outlook, 2015 - 2026

FIG 3.&nbsp;&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

FIG 4.&nbsp;&nbsp;&nbsp;&nbsp; PEST analysis